At first, Gupta and Sharma tested the effect of vanillin, as a selective agonist of transient receptor potential vanilloid subtype 1 (TRPV1), in 3-nitropropionic acid (3-NPA)-induced HD in rats (in vivo model of HD) [47]. The gene discussed is TRPV1; the disease is Huntington disease.